Category: ADHD - Child
Keywords: ADHD - Child / Adolescent | Treatment Integrity / Adherence / Compliance | Hispanic Americans
Presentation Type: Symposium
Background: Prevalence rates of ADHD for Hispanic children are half that of non-Hispanics. However, recent research suggests that prevalence rates and use of medication to treat ADHD are increasing among Hispanic children. Differences in diagnosis and treatment are a result of barriers to health care and of individual and cultural factors. Determining what factors contribute to this unmet need is an important area to continue to explore.
Methods and Results: The present study examined treatment utilization and adherence of 224 families (163 Hispanic) of treatment naïve children with ADHD (M age = 7.59, SD = 1.96). Families were randomly assigned to receive behavior therapy (BT) or stimulant medication (MED); after 6 months, families had free access to either treatment for 24 months. Utilization was measured using number of BT sessions attended and total dosage of MED (in mg); adherence was measured using the percentage of prescribed MED taken. Comorbid symptoms were assessed using the CBCL and DBD. Satisfaction with treatment was assessed at endpoint. Regression analyses took into account ADHD symptom severity. Spanish speaking Hispanic families displayed significantly higher levels of feasibility issues for receiving counseling to treat their child’s ADHD. Knowledge of ADHD, comorbid anxiety/depressive symptoms, and satisfaction with treatment were predictive of greater utilization of BT; willingness to use medication and comorbid CD symptoms were associated with less utilization of BT. Medication willingness was associated with greater MED dosage. Counseling willingness and treatment satisfaction were associated with MED adherence. Coming from a Spanish Speaking family was associated with significantly less utilization of BT, taking into account several of the other variables. Ethnicity was significantly associated with MED adherence, taking into account several of the other variables.
Conclusions: While Hispanic families are utilizing treatment at relatively equal rates to non-Hispanic families overall, acculturation appears to be an important variable in predicted decreased use of BT and coming from a Hispanic family in general appears to be related to lower adherence to prescribed MED. Presentation will discuss how this sample compares to Hispanic families as a whole and what this and aspects of the study mean for limiting barriers to treatment.
Penn State Hershey Medical Center
Saturday, November 18
1:45 PM – 3:15 PM
The asset you are trying to access is locked. Please enter your access key to unlock.